{"nct_id":"NCT05246514","title":"A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2022-07-13","start_date_type":"ACTUAL","primary_completion_date":"2023-09-23","primary_completion_date_type":"ACTUAL","completion_date":"2026-03-16","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AZN"]}